Status:

RECRUITING

APIXABAN App Study

Lead Sponsor:

Dong-Ju Choi

Conditions:

Atrial Fibrillation

Eligibility:

All Genders

19+ years

Phase:

NA

Brief Summary

The aim of this clinical trial is to evaluate whether the medication reminder app and video call can improve medication adherence to apixaban in patients with AF and comorbidities. Patients with AF a...

Eligibility Criteria

Inclusion

  • Participants must meet all of the following criteria:
  • Adults aged 19 years or older with a diagnosis of atrial fibrillation (AF)
  • Presence of at least one of the following cardiovascular or metabolic comorbidities:
  • A. Heart failure
  • B. Hypertension
  • C. Coronary artery disease
  • D. Peripheral arterial disease
  • E. Diabetes mellitus
  • F. Stroke
  • G. Other cardiac diseases requiring treatment
  • Currently taking or planning to initiate oral anticoagulation therapy with apixaban
  • Able to use a smartphone with an Android operating system
  • Voluntarily provided written informed consent to participate in the clinical trial after being adequately informed of its purpose, procedures, and potential risks
  • 2\. Exclusion Criteria
  • Participants will be excluded if any of the following conditions apply:
  • Creatinine clearance (CCr) \< 15 mL/min
  • Presence of moderate to severe mitral stenosis
  • History of mitral valve repair or replacement
  • Clinically significant history of alcohol or substance abuse
  • Deemed by the investigator to be legally or psychologically unsuitable for participation in the clinical trial
  • Participation in another clinical trial involving investigational drugs within 4 weeks prior to screening
  • Declines or is unwilling to provide informed consent for participation in this study

Exclusion

    Key Trial Info

    Start Date :

    March 1 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    December 31 2025

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT06903845

    Start Date

    March 1 2025

    End Date

    December 31 2025

    Last Update

    April 6 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Seoul National University Bundang Hospital

    Seongnam, Gyeonggido, South Korea, 13620

    APIXABAN App Study | DecenTrialz